methotrexate

Generic: methotrexate

Labeler: mylan institutional inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name methotrexate
Generic Name methotrexate
Labeler mylan institutional inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

methotrexate sodium 2.5 mg/1

Manufacturer
Mylan Institutional Inc.

Identifiers & Regulatory

Product NDC 51079-670
Product ID 51079-670_3a866716-12c5-4380-e063-6394a90ae975
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA081235
Listing Expiration 2026-12-31
Marketing Start 1995-07-13

Pharmacologic Class

Classes
folate analog metabolic inhibitor [epc] folic acid metabolism inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51079670
Hyphenated Format 51079-670

Supplemental Identifiers

RxCUI
105585
UNII
3IG1E710ZN

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name methotrexate (source: ndc)
Generic Name methotrexate (source: ndc)
Application Number ANDA081235 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/1
source: ndc
Packaging
  • 20 BLISTER PACK in 1 CARTON (51079-670-05) / 1 TABLET in 1 BLISTER PACK (51079-670-01)
source: ndc

Packages (1)

Ingredients (1)

methotrexate sodium (2.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3a866716-12c5-4380-e063-6394a90ae975", "openfda": {"unii": ["3IG1E710ZN"], "rxcui": ["105585"], "spl_set_id": ["8df0780e-0fbd-4ab8-80b0-7a5eaa08ec0a"], "manufacturer_name": ["Mylan Institutional Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "20 BLISTER PACK in 1 CARTON (51079-670-05)  / 1 TABLET in 1 BLISTER PACK (51079-670-01)", "package_ndc": "51079-670-05", "marketing_start_date": "19950713"}], "brand_name": "Methotrexate", "product_id": "51079-670_3a866716-12c5-4380-e063-6394a90ae975", "dosage_form": "TABLET", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "51079-670", "generic_name": "methotrexate", "labeler_name": "Mylan Institutional Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Methotrexate", "active_ingredients": [{"name": "METHOTREXATE SODIUM", "strength": "2.5 mg/1"}], "application_number": "ANDA081235", "marketing_category": "ANDA", "marketing_start_date": "19950713", "listing_expiration_date": "20261231"}